| scholarly article | Q13442814 |
| P2093 | author name string | Yan Li | |
| Xin Zhou | |||
| Yu Tao | |||
| Xuan Cai | |||
| Zhihua Lv | |||
| P2860 | cites work | Impact of intravenous contrast enhancement phase on target definition for hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (IHC): Observations from patients enrolled on a prospective phase 2 trial. | Q38645162 |
| MiR-21 promoted proliferation and migration in hepatocellular carcinoma through negative regulation of Navigator-3. | Q38849387 | ||
| MiR-214 inhibits cell growth in hepatocellular carcinoma through suppression of β-catenin | Q39258962 | ||
| High expression of miR-15b predicts poor prognosis for hepatocellular carcinoma after curative hepatectomy | Q40632008 | ||
| MiR-21 and miR-183 can simultaneously target SOCS6 and modulate growth and invasion of hepatocellular carcinoma (HCC) cells | Q40984947 | ||
| Early hepatocellular carcinoma: definition and diagnosis | Q41824372 | ||
| Retraction: miR-122 Regulates Tumorigenesis in Hepatocellular Carcinoma by Targeting AKT3. | Q42010835 | ||
| Hepatic and serum levels of miR-122 after chronic HCV-induced fibrosis | Q42985352 | ||
| Circulating tumour DNA methylation markers for diagnosis and prognosis of hepatocellular carcinoma. | Q45945288 | ||
| The liver-specific microRNA-122*, the complementary strand of microRNA-122, acts as a tumor suppressor by modulating the p53/mouse double minute 2 homolog circuitry. | Q48287375 | ||
| Risk of hepatocellular carcinoma in HBV cirrhotic patients assessed by the combination of miR-122, AFP and PIVKA-II. | Q50561205 | ||
| Expression of serum miR-16, let-7f, and miR-21 in patients with hepatocellular carcinoma and their clinical significances. | Q51149290 | ||
| Screening for hepatocellular carcinoma | Q74027220 | ||
| Circulating microRNAs, miR-21, miR-122, and miR-223, in patients with hepatocellular carcinoma or chronic hepatitis | Q83181319 | ||
| Effects and mechanism of miR-214 on hepatocellular carcinoma | Q85199078 | ||
| Beginnings of a "gene cloud" definition in hepatocellular carcinoma | Q87731502 | ||
| Comparison of international guidelines for noninvasive diagnosis of hepatocellular carcinoma | Q27014969 | ||
| Global cancer statistics, 2012 | Q27860501 | ||
| Management of hepatocellular carcinoma: An update | Q27860530 | ||
| Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma | Q30479629 | ||
| OIP5, a target of miR-15b-5p, regulates hepatocellular carcinoma growth and metastasis through the AKT/mTORC1 and β-catenin signaling pathways | Q33566841 | ||
| A novel GSK-3 beta-C/EBP alpha-miR-122-insulin-like growth factor 1 receptor regulatory circuitry in human hepatocellular carcinoma | Q34147202 | ||
| The incidence and epidemiology of hepatocellular carcinoma: a global and regional perspective | Q34625481 | ||
| Profiling microRNA expression in hepatocellular carcinoma reveals microRNA-224 up-regulation and apoptosis inhibitor-5 as a microRNA-224-specific target. | Q34758345 | ||
| Bead-based microarray analysis of microRNA expression in hepatocellular carcinoma: miR-338 is downregulated | Q34983322 | ||
| Risk factors for naturally-occurring early-onset hepatocellular carcinoma in patients with HBV-associated liver cirrhosis in China | Q35173805 | ||
| miR-214/199a/199a* cluster levels predict poor survival in hepatocellular carcinoma through interference with cell-cycle regulators | Q36729569 | ||
| Biomarker MicroRNAs for Diagnosis, Prognosis and Treatment of Hepatocellular Carcinoma: A Functional Survey and Comparison | Q37472263 | ||
| A novel microRNAs expression signature for hepatocellular carcinoma diagnosis and prognosis | Q37702806 | ||
| Diagnostic and prognostic value of circulating miR-21 for cancer: a systematic review and meta-analysis | Q38146339 | ||
| Current biomarkers for hepatocellular carcinoma: Surveillance, diagnosis and prediction of prognosis | Q38366584 | ||
| A meta-analysis of contrast-enhanced ultrasound for small hepatocellular carcinoma diagnosis | Q38372878 | ||
| Rate of Nonsurveillance and Advanced Hepatocellular Carcinoma at Diagnosis in Chronic Liver Disease | Q38599835 | ||
| P433 | issue | 2 | |
| P921 | main subject | biomarker | Q864574 |
| P304 | page(s) | 990-997 | |
| P577 | publication date | 2018-02-01 | |
| P1433 | published in | International Journal of Clinical and Experimental Pathology | Q6051341 |
| P1476 | title | Cluster of specified microRNAs in tissues and serum as biomarkers for early diagnosis of hepatocellular carcinoma | |
| P478 | volume | 11 |
Search more.